AMGFormer: A Multimodal Attention Graph Former Framework for Parkinson's Disease Classification Using Enhanced MRI Images
Keywords:
Parkinson's Disease Classification; Magnetic Resonance Imaging (MRI); Graph Transformer; Self Supervised Learning; Medical Masked Autoencoder (MedMAE); Multimodal Feature Fusion; Adaptive Neuro Enhancement Filter (ANEF); Attention MechanismAbstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder whose early diagnosis using magnetic resonance imaging (MRI) remains challenging because of subtle structural abnormalities and limited labeled medical data. Existing approaches, including radiomics-based texture analysis, multimodal MRI–genetic fusion models, and graph neural network frameworks, have demonstrated promising performance but often depend on handcrafted features, multimodal clinical data, or limited relational modeling capabilities. To address these limitations, this study proposes an Attention-guided Multimodal Graph Former (AMGFormer) for MRI-only PD classification. MRI images from the Parkinson Multi-Modal Dataset 2.0 are first preprocessed through resizing and intensity normalization and subsequently enhanced using an Adaptive Neuro-Enhancement Filter (ANEF) to improve disease-relevant anatomical structures. Multimodal representations are extracted by combining Gray Level Co-occurrence Matrix (GLCM) and Local Phase Quantization (LPQ) texture descriptors, structural morphological features, and deep semantic embeddings learned through a Medical Masked Autoencoder (MedMAE) using self-supervised learning. The fused features are transformed into a similarity graph and processed using a Graph Transformer with multi-head attention to capture complex inter-feature dependencies. The framework was implemented using Python 3.11, PyTorch 2.3, CUDA 12.1, and Scikit-Learn. Experimental results achieved 96.80% accuracy, 96.60% precision, 97.40% recall, 96.50% F1-score, and 97.00% AUC. Five fold cross-validation yielded a mean accuracy of 96.80% with a standard deviation of 0.27, demonstrating robustness and superior performance over existing MRI-based and multimodal PD diagnostic approaches.
Downloads
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

